CVR number 34352542
Industry 46.4610 Wholesale of pharmaceutical goods

NORDIC MEDICAL SOLUTIONS ApS

 

Quicksearch
from your own companies
Analyst: XBRLDenmark
 
Loading...

Loading...

Loading...

Loading...

 
Loading...
Bankruptcy Risk 
2019
2020/6
2020
2021/6
2021
2022/6
2022
2023/6
2023
2024/6
Bankruptcy risk for industry  1.1% 1.1% 1.1% 1.1% 1.1%  
Bankruptcy risk  2.4% 3.2% 2.1% 0.6% 1.1%  
Credit score (0-100)  64 55 66 98 83  
Credit rating  BBB BBB A AA A  
Credit limit (kDKK)  0.3 0.0 3.6 3,793.0 2,748.3  
How are these values calculated?
 
View the automatically generated explanation of bankruptcy risk

Income statement (kDKK) 
2019
2020/6
2020
2021/6
2021
2022/6
2022
2023/6
2023
2024/6
Net sales  0 0 0 0 0  
Gross profit  34,516 55,962 50,656 45,366 50,098  
EBITDA  26,202 47,152 30,766 16,157 38,519  
EBIT  26,202 47,152 30,766 16,000 38,463  
Pre-tax profit (PTP)  19,418.0 35,350.0 22,211.0 14,872.2 37,592.1  
Net earnings  19,418.0 35,350.0 22,211.0 11,529.6 29,275.2  
Pre-tax profit without non-rec. items  26,202 47,152 30,766 14,872 37,592  
 
See the entire income statement

Balance sheet (kDKK) 
2019
2020/6
2020
2021/6
2021
2022/6
2022
2023/6
2023
2024/6
Tangible assets total  0.0 0.0 0.0 570 514  
Shareholders equity total  22,418 41,350 31,211 22,030 36,275  
Interest-bearing liabilities  0.0 0.0 0.0 24,243 14,002  
Balance sheet total (assets)  81,582 96,455 88,182 58,992 67,816  
Net Debt  0.0 0.0 0.0 22,630 10,415  
 
See the entire balance sheet

Volume 
2019
2020/6
2020
2021/6
2021
2022/6
2022
2023/6
2023
2024/6
Net sales  0 0 0 0 0  
Net sales growth  0.0% 0.0% 0.0% 0.0% 0.0%  
Gross profit  34,516 55,962 50,656 45,366 50,098  
Gross profit growth  0.8% 62.1% -9.5% -10.4% 10.4%  
Employees  0 0 0 14 16  
Employee growth %  0.0% 0.0% 0.0% 0.0% 14.3%  
Employee expenses  0.0 0.0 0.0 0.0 0.0  
Balance sheet total (assets)  81,582 96,455 88,182 58,992 67,816  
Balance sheet change%  88.3% 18.2% -8.6% -33.1% 15.0%  
Added value  26,202.0 47,152.0 30,766.0 15,999.9 38,519.3  
Added value %  0.0% 0.0% 0.0% 0.0% 0.0%  
Investments  0 0 0 1,049 99  
Net sales trend  0.0 0.0 0.0 0.0 0.0  
EBIT trend  4.0 5.0 5.0 5.0 5.0  

Profitability 
2019
2020/6
2020
2021/6
2021
2022/6
2022
2023/6
2023
2024/6
EBITDA %  0.0% 0.0% 0.0% 0.0% 0.0%  
EBIT %  0.0% 0.0% 0.0% 0.0% 0.0%  
EBIT to gross profit (%)  75.9% 84.3% 60.7% 35.3% 76.8%  
Net Earnings %  0.0% 0.0% 0.0% 0.0% 0.0%  
Profit before depreciation and extraordinary items %  0.0% 0.0% 0.0% 0.0% 0.0%  
Pre tax profit less extraordinaries %  0.0% 0.0% 0.0% 0.0% 0.0%  
ROA %  42.0% 53.0% 33.3% 21.9% 60.8%  
ROI %  42.0% 53.0% 33.3% 23.9% 79.7%  
ROE %  85.7% 110.9% 61.2% 43.3% 100.4%  

Solidity 
2019
2020/6
2020
2021/6
2021
2022/6
2022
2023/6
2023
2024/6
Equity ratio %  100.0% 100.0% 100.0% 38.6% 54.1%  
Relative indebtedness %  0.0% 0.0% 0.0% 0.0% 0.0%  
Relative net indebtedness %  0.0% 0.0% 0.0% 0.0% 0.0%  
Net int. bear. debt to EBITDA, %  0.0% 0.0% 0.0% 140.1% 27.0%  
Gearing %  0.0% 0.0% 0.0% 110.0% 38.6%  
Net interest  0 0 0 0 0  
Financing costs %  0.0% 0.0% 0.0% 10.1% 5.2%  

Liquidity 
2019
2020/6
2020
2021/6
2021
2022/6
2022
2023/6
2023
2024/6
Quick Ratio  0.0 0.0 0.0 0.7 0.9  
Current Ratio  0.0 0.0 0.0 2.6 2.9  
Cash and cash equivalent  0.0 0.0 0.0 1,613.8 3,586.8  

Capital use efficiency 
2019
2020/6
2020
2021/6
2021
2022/6
2022
2023/6
2023
2024/6
Trade debtors turnover (days)  0.0 0.0 0.0 0.0 0.0  
Trade creditors turnover (days)  0.0 0.0 0.0 0.0 0.0  
Current assets / Net sales %  0.0% 0.0% 0.0% 0.0% 0.0%  
Net working capital  0.0 0.0 0.0 35,827.6 43,179.5  
Net working capital %  0.0% 0.0% 0.0% 0.0% 0.0%  

Employee efficiency 
2019
2020/6
2020
2021/6
2021
2022/6
2022
2023/6
2023
2024/6
Net sales / employee  0 0 0 0 0  
Added value / employee  0 0 0 1,143 2,407  
Employee expenses / employee  0 0 0 0 0  
EBITDA / employee  0 0 0 1,154 2,407  
EBIT / employee  0 0 0 1,143 2,404  
Net earnings / employee  0 0 0 824 1,830